Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine

Livedo reticularis on bilateral knees after the third dose of messenger RNA-1273 SARS-CoV-2 vaccine

Bibliographic Details
Main Authors:	Michelle Amy Mintz, PhD, Neha Jariwala, MD, Victoria Fang, MD, PhD, Alexandra Coromilas, MD, Misha Rosenbach, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	JAAD International
Subjects:	COVID-19 drug eruption livedo Moderna mRNA mRNA-1273
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328722000207

Similar Items

Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
by: Daniele Focosi, et al.
Published: (2022-11-01)

Generalized livedo reticularis: A rare variety
by: Pallavi Goyal, et al.
Published: (2019-01-01)

A case of recurrent fixed drug eruption following the administration of 2 different coronavirus disease 2019 vaccines verified using intradermal and patch tests
by: Jung Eun Seol, MD, PhD, et al.
Published: (2023-03-01)

Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine
by: Luca Valore, et al.
Published: (2023-04-01)

HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
by: Juan Francisco Gutiérrez-Bautista, et al.
Published: (2022-03-01)

Amantadine-induced livedo reticularis - Case report
by: Maria Victória Quaresma, et al.
Published: (2015-10-01)

Livedo reticularis due to pellagra in a two year old child
by: Biju Vasudevan, et al.
Published: (2014-01-01)

Livedo reticularis in Graves' disease: Just a coincidence?
by: Saurabh Gaba, et al.
Published: (2022-01-01)

Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients
by: Wei-Chen Lee, et al.
Published: (2023-03-01)

Pityriasis rosea–like rash after messenger RNA COVID-19 vaccination: A case report and review of the literatureCapsule Summary
by: Jordan E. Buckley, MD, et al.
Published: (2022-06-01)

Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review
by: Angel Shabu, et al.
Published: (2023-12-01)

Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
by: Farah M. Shurrab, et al.
Published: (2022-01-01)

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
by: Bethany Girard, et al.
Published: (2024-03-01)

Matrices Activated with Messenger RNA
by: Raquel Martinez-Campelo, et al.
Published: (2023-01-01)

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial
by: Abdi Naficy, et al.
Published: (2024-12-01)

Advancing mRNA technologies for therapies and vaccines: An African context
by: Dylan Kairuz, et al.
Published: (2022-10-01)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
by: Gabriele Anichini, et al.
Published: (2022-05-01)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
by: Sammy Patyna, et al.
Published: (2022-04-01)

The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
by: Karol Kurpiejewski, et al.
Published: (2024-02-01)

Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
by: Dario Garcia-Dominguez, et al.
Published: (2022-11-01)

Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity
by: Denise A Warzak, et al.
Published: (2023-10-01)

Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
by: Magdalena M. Żak, et al.
Published: (2023-08-01)

Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
by: Yves Michiels, et al.
Published: (2021-08-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
by: Md. Motiar Rahman, et al.
Published: (2021-03-01)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
by: Miriam Echaide, et al.
Published: (2023-03-01)

Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment
by: Kaleen N. Hayes, et al.
Published: (2023-08-01)

Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine
by: Angel Shabu, et al.
Published: (2023-12-01)

Case report: SARS-CoV-2 specific T-cells are associated with myocarditis after COVID-19 vaccination with mRNA-1273
by: Ulrik Stervbo, et al.
Published: (2023-03-01)

Localized livedo racemosa as an indicator for giant cell arteritis
by: Katharina Drerup, MD, et al.
Published: (2022-06-01)

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework
by: Xuan Wang, et al.
Published: (2023-09-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
by: Min Tang, et al.
Published: (2023-04-01)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

Antibody Response Induced by BNT162b2 and mRNA-1273 Vaccines against the SARS-CoV-2 in a Cohort of Healthcare Workers
by: Juan F. Delgado, et al.
Published: (2022-06-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Albert Liu, et al.
Published: (2022-07-01)

COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review
by: Maulidina Agustin, et al.
Published: (2023-01-01)

Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling
by: Orazio Palmieri, et al.
Published: (2017-07-01)

Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
by: Natsuko Oyama, et al.
Published: (2021-10-01)

Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
by: Soledad González, et al.
Published: (2022-09-01)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
by: Yusi Wang, et al.
Published: (2022-02-01)

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
by: Xueliang Yu, et al.
Published: (2021-11-01)